智通财经APP讯,三叶草生物-B(02197)发布截至2024年12月31日止年度业绩,收入3841.9万元,同比减少2.13%;年内亏损9.03亿元,同比扩大552.11%;经调整年内亏损8.87亿元,同比扩大943.41%;每股亏损0.72元。
年内亏损由截至2023年12月31日止年度的1.385亿元增加7.649亿元至截至2024年12月31日止年度的9.034亿元,主要由于于2023年确认为其它收入的自CEPI收取的资金以及存货减值拨备的非经常性综合影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.